Category : Search result: Pharmacy vs Biotechnology


ICAR slams GM-Free India's rice data claims as baseless

In a sharp rebuttal, ICAR challenges GM-Free India's allegations about unauthorized GM rice field trials, calling them unfounded and detrimental to agricultural advancement. Get the full story on this scientific controversy.

Novartis Nears $1.7B Avidity Biosciences Acquisition

Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.

Page 2 of 2